Skip to content
Search

Latest Stories

GPhC appoints Gisela Abbam as its new chair

General Pharmaceutical Council (GPhC) has appointed Gisela Abbam as its new chair.

Appointment of Abbam, who will assume office on March 14, 2022, was made by the Privy Council after a robust selection process which was scrutinised by the Professional Standards Authority.


She will take over from the current chair, Nigel Clarke, who has been in position since 2014 and has completed the statutory maximum eight years in office.

Commenting on her appointment, Abbam said: "I am delighted and honoured to be appointed as the new chair of the General Pharmaceutical Council and I look forward to leading the Council to achieve its vision of safe and effective pharmacy care at the heart of healthier communities.

“Covid-19 highlighted the increased role of pharmacists, pharmacy technicians and pharmacies in providing clinical services. Effective standards and regulation can help pharmacy to provide more support to patients and the public at large. I look forward to working with Council, the Executive team and staff and collaborating with other organisations to improve the health of people using pharmacy services."

Welcoming Abbam to the Council, Clarke, said: “Gisela is joining the GPhC at an exciting time of major changes in both pharmacy and health regulation. I am sure her vast experience in healthcare will help the GPhC drive forward the aims set out in our Vision 2030, and bring a real focus on the difference we want to make for patients and the public.”

Previously, Abbam was chair of the British Science Association (BSA). During her tenure, she led the BSA’s Council and championed the BSA mission and vision, driving forward an agenda on equality, diversity, and inclusion in STEM (Science, Technology, Engineering and Maths).

She has worked in collaboration with governments, the World Health Organisation, the United Nations, and other multilateral organisations to improve health outcomes for people across the world.

She is also the senior director government affairs for EMEAI at PerkinElmer, a global provider of end-to-end solutions that help scientists, researchers and clinicians better diagnose disease, discover new and more personalised drugs, monitor the safety and quality of food.

Besides, she serves on a number of advisory committees and sits on the Board of Everywoman Ltd., an organisation dedicated to advancing women in business.

Many in the industry congratulated the Council on the new appointment.

Welcoming the new GPhC chair, Mark Lyonette, chief executive of National Pharmacy Association wrote on twitter, “looking forward to meeting @gmabbam once she starts.

Mark tweet

More For You

Vaccine-preventable infections costing UK billions

Effective interventions are needed to prevent hospitalisations

Vaccine-preventable infections costing UK billions

Effective interventions are having a positive impact but more needs to be done to combat vaccine-preventable infections after data revealed today showed that it accounted for 20 per cent of hospital bed usage in the UK between 2023 to 2024 at a cost of almost £6 billion.

The return of social mixing, international travel and migration following the COVID-19 pandemic have contributed to the rise in both endemic disease and vaccine-preventable infections, according to the UK Health Security Agency's (UKHSA).

Keep ReadingShow less
Economic analysis of pharmacy finances will be published ‘imminently’ - Stephen Kinnock

Stephen Kinnock also confirms that the outcome of the negotiations with CPE will be announced "very soon."

parliamentlive.tv

NPA collective action “premature, unnecessary and detrimental to patients” - Stephen Kinnock

Health Minister Stephen Kinnock has announced that the government will be releasing the independent economic analysis of pharmacy finances “imminently.”

Responding to a question from shadow health minister Dr. Luke Evans in Parliament today (25), Kinnock criticised the National Pharmacy Association’s (NPA) collective action as “premature, unnecessary, and detrimental to community pharmacy patients.”

Keep ReadingShow less
NPA members are expected reduce opening hours and services from next week

NPA members are expected reduce opening hours and services from next week

Pic credit: iStock

NPA will become more “militant” as wait for pharmacy contract goes on

The government has been warned by the National Pharmacy Association (NPA) that community pharmacy will not back down from collective action and reducing opening hours from April 1st.

NPA board member, Ashley Cohen, told LBC today that the sector was in a "desperate situation" and that the representative body will do “whatever we can to protect our sector”.

Keep ReadingShow less
Community pharmacy needs investment and support to deliver neighbourhood health, says CCA chief

Community pharmacies see patients more than anyone else in the primary care system.

Getty Images

Community pharmacy key to neighbourhood health, but investment needed, says CCA chief

Community pharmacies can play a vital role in delivering a ‘neighbourhood health service’, provided they receive the necessary investment and support, according to Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA).

Harrison's comments come in response to a new report from think tank Reform, titled Designing a Neighbourhood Health Service, which outlines key principles for achieving the government's vision of a more community-focused healthcare system.

Keep ReadingShow less
Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less